Trade Mark Journal No.2024/041 11 October 2024

UK00004101300 18 September 2024 (42,44)

GENOUS

International priority date claimed: 17 September 2024 (United States of America) (98755109)

Class 42: Biological research and analysis; Medical research services; Scientific research, namely scientific research relating to genetic alterations; Research in the field of genetic diseases; Consulting services in the field of genetic science; Genetic sequencing services for scientific and medical purposes; Providing medical research information in the field of genetics; Software as a service (SAAS) services featuring software used for the analysis of genomes, molecular diagnostic tests to predict treatment response and improve diagnostics in the medical, scientific and biological fields; Interactive web-based communication platform as a service featuring computer software platforms for medical and biological data sharing for disease, treatment, trial, outcome and molecular diagnostic test results for decision support.
Class 44: Genetic testing for medical purposes, Genetic testing for cancer risk for medical purposes; Genetic testing for medical purposes for detecting genetic predispositions; Genetic counseling; Medical counseling for the medical treatment of genetic predispositions; Providing information about genetic counseling; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Health counseling; Medical clinic services; Medical services; Pharmaceutical advice; Telemedicine services; Health care services, namely, personalized therapy services, clinical decision support services and evidence-based treatment decisions; Consulting services in the field of health care to assist with biomedical and clinical decisions; medical diagnostic testing, monitoring and reporting services in personalized medicine.

GENOMATE HEALTH INC.

Representative: Fox Williams LLP